SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor

Oregon Health & Science University at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Oregon Health & Science University brings 2 presentations to SITC 2026 in Phoenix. Its program centres on how sex-specific factors shape responses to immunotherapy and on managing immune-related side effects in people with melanoma. The EMPOWER trial tests whether closer symptom monitoring and faster access to specialists help these patients.

OrganizationSITC 2026 Attendance
Universities & research institutes
Public academic health centre in Portland, home of the Knight Cancer Institute.
Session
Thu Nov 5
12:00pm–1:30pm
Poster
Fri Nov 6
12:15–1:45pm
5:30–7pm
Session
Sat Nov 7
5:20pm–6:40pm
Sex-specific Factors that Influence Immune Fitness and Response to Immunotherapy
Tumor biology
  1. 5:22pm–5:37pmBreast Cancer Risk in the Early Post-Partum PeriodUniversity of Colorado
  2. 5:37pm–5:52pmBreast Cancer Anti-Tumour Immunity and Reproductive HistoryPeter MacCallum Cancer Centre
  3. 5:52pm–6:07pmSex Differences and Cancer EtiologyCedars-Sinai
  4. 6:07pm–6:17pmHost FPR2 limits immunotherapy response through sex dependent macrophage niches in pancreatic ductal adenocarcinomaKarolinska Institutet
  5. 6:17pm–6:27pmCell-intrinsic sex differences shape exhausted CD8+ T cell fateBaylor College of Medicine

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Oregon Health & Science University

Tell us what you sell and we’ll find the people at Oregon Health & Science University most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction